We are live on
!
Find out more
GPCM
Granite Point Capital Management Portfolio holdings
AUM
$4.9M
1-Year Est. Return
38.41%
This Fund
S&P 500
This Quarter
Est. Return
-13.03%
1 Year Est. Return
+38.41%
3 Year Est. Return
+124.67%
5 Year Est. Return
+295.96%
10 Year Est. Return
–
AUM
$146M
AUM Growth
-$198M
(-58%)
Cap. Flow
-$167M
Cap. Flow
% of AUM
-114.33%
Top 10 Holdings %
Top 10 Hldgs %
55.25%
Holding
117
New
19
Increased
20
Reduced
38
Closed
29
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AXON
Axon Enterprise
AXON
|
+$3.53M |
| 2 |
XENT
Intersect ENT, Inc
XENT
|
+$2.78M |
| 3 |
Apple
AAPL
|
+$2.76M |
| 4 |
Meta Platforms (Facebook)
META
|
+$2.61M |
| 5 |
HIMX
Himax Technologies
HIMX
|
+$1.86M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
OVTI
OMNIVISION TECHNOLOGIES INC
OVTI
|
+$6.71M |
| 2 |
WX
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
|
+$4.96M |
| 3 |
TTPH
Tetraphase Pharmaceuticals, Inc.
TTPH
|
+$3.57M |
| 4 |
CSII
Cardiovascular Systems, Inc.
CSII
|
+$3.38M |
| 5 |
Motorcar Parts of America
MPAA
|
+$3.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.56% |
| 2 | Technology | 9.18% |
| 3 | Consumer Discretionary | 8.62% |
| 4 | Industrials | 7.01% |
| 5 | Communication Services | 4.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
PUT
iShares Russell 2000 ETF
IWM
$79.1B
| $39.3M | 26.94% |
360,000
-1,165,000
| -76% | -$138M |
|
|
ADPT
2
DELISTED
Adeptus Health Inc
ADPT
| $7.98M | 5.47% |
98,845
+9,747
| +11% | +$1.01M |
|
|
3
Meta Platforms (Facebook)
META
$1.49T
| $5.39M | 3.7% |
60,000
+28,408
| +90% | +$2.61M |
|
|
NVRO
4
DELISTED
NEVRO CORP.
NVRO
| $5.38M | 3.69% |
115,927
-50,523
| -30% | -$2.45M |
|
|
HIMX
5
Himax Technologies
HIMX
$2.03B
| $5.13M | 3.52% |
643,952
+250,672
| +64% | +$1.86M |
|
|
XENT
6
DELISTED
Intersect ENT, Inc
XENT
| $4.68M | 3.21% |
200,000
+100,796
| +102% | +$2.78M |
|
|
ARIA
7
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $3.71M | 2.54% |
634,772
-70,808
| -10% | -$545K |
|
|
8
Apple
AAPL
$4.97T
| $3.31M | 2.27% |
120,000
+94,080
| +363% | +$2.76M |
|
|
AXON
9
Axon Enterprise
AXON
$42.8B
| $3.3M | 2.26% |
150,000
+133,800
| +826% | +$3.53M |
|
10
Protolabs
PRLB
$1.7B
| $2.44M | 1.67% |
36,400
+8,400
| +30% | +$599K |
|
11
Good Times Restaurants
GTIM
$14.9M
| $2.34M | 1.6% |
374,090
+82,916
| +28% | +$620K |
|
12
Amazon
AMZN
$2.44T
| $2.15M | 1.47% |
84,000
+45,120
| +116% | +$1.14M |
|
|
TNAV
13
DELISTED
Telenav Inc.
TNAV
| $2.09M | 1.43% |
268,012
+151,332
| +130% | +$1.1M |
|
|
DOC
14
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $2.05M | 1.4% |
135,808
+12,688
| +10% | +$195K |
|
|
CBPO
15
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $1.8M | 1.23% |
20,000
-9,160
| -31% | -$967K |
|
|
MB
16
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
| $1.77M | 1.21% |
113,293
+8,293
| +8% | +$109K |
|
|
XUE
17
DELISTED
XUEDA EDUCATION GROUP ADS REPTG 2 ORD SHS
XUE
| $1.75M | 1.2% |
339,295
-154,633
| -31% | -$712K |
|
18
CALL
iShares MSCI Emerging Markets ETF
EEM
$27.5B
| $1.64M | 1.12% |
+50,000
| New | +$1.77M |
|
|
CELG
19
DELISTED
Celgene Corp
CELG
| $1.54M | 1.05% |
14,198
-778
| -5% | -$96.5K |
|
|
WUBA
20
DELISTED
58.com Inc
WUBA
| $1.51M | 1.03% |
32,000
+24,112
| +306% | +$1.25M |
|
|
BEAT
21
DELISTED
BioTelemetry, Inc.
BEAT
| $1.47M | 1.01% |
120,000
-81,832
| -41% | -$1.04M |
|
22
Gentex
GNTX
$5.1B
| $1.46M | 1% |
+94,009
| New | +$1.49M |
|
|
IMPR
23
DELISTED
IMPRIVATA, INC COM
IMPR
| $1.42M | 0.97% |
80,046
-5,074
| -6% | -$90.7K |
|
24
Evolent Health
EVH
$371M
| $1.4M | 0.96% |
87,828
-5,158
| -6% | -$101K |
|
25
General Motors
GM
$80.9B
| $1.35M | 0.93% |
45,000
-11,000
| -20% | -$337K |
|
Similar funds
MAM
CCM
BGCI
CAM
EAM
SM
TPL
RC
Granite Point Capital Management's Q3 2015 Portfolio in Review
As of Q3 2015, Granite Point Capital Management held 117 positions worth $146M, down 58% from $344M the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Granite Point Capital Management withdrew a net $167M in Q3 2015, closing 29 positions and reducing 38 holdings. Its most notable exit was Tetraphase Pharmaceuticals, Inc., an estimated $3.57M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Granite Point Capital Management opened a new position in Gentex worth $1.46M.
- Granite Point Capital Management's largest Q3 2015 buy was Gentex: 94,009 shares worth $1.46M.
- Granite Point Capital Management added most to Axon Enterprise in Q3 2015, an estimated $3.53M increase.
- Granite Point Capital Management's biggest Q3 2015 reduction was OMNIVISION TECHNOLOGIES INC, cutting an estimated $6.71M.
- Granite Point Capital Management fully exited Tetraphase Pharmaceuticals, Inc. in Q3 2015, selling an estimated $3.57M.
- Granite Point Capital Management's ten largest holdings make up 55% of its $146M portfolio in Q3 2015.
- Granite Point Capital Management opened 19 new positions and closed 29 in Q3 2015.
- Granite Point Capital Management's portfolio value fell 58% quarter-over-quarter to $146M.
Based on Granite Point Capital Management's 13F filing for Q3 2015, filed 13 Nov 2015.